EQT
59
6
EIX
45
-2
GWW
53
12
CTAS
37
-3
CCL
58
-2
BSX
67
-2
ZION
64
4
KR
61
2
MU
48
-7
WM
71
-3
VTR
54
-6
TAP
60
2
ILMN
25
2
FMC
31
-3
MAT
51
8
ALLE
35
-2
MMC
65
8
KSS
20
-3
GRMN
43
3
VIX
44
-3
EQT
59
6
EIX
45
-2
GWW
53
12
CTAS
37
-3
CCL
58
-2
BSX
67
-2
ZION
64
4
KR
61
2
MU
48
-7
WM
71
-3
VTR
54
-6
TAP
60
2
ILMN
25
2
FMC
31
-3
MAT
51
8
ALLE
35
-2
MMC
65
8
KSS
20
-3
GRMN
43
3
VIX
44
-3
Financhill
Back

Partners Group Holding AG Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
54

PGPHF
Partners Group Holding AG

Last Price:
$1,501.31
Seasonality Move:
12.28%
Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
$283.22
Seasonality Move:
3.3%
Buy
54
Partners Group Holding AG (PGPHF) is a Buy

Is Partners Group Holding AG a Buy, Sell or Hold?

  • The current Partners Group Holding AG [PGPHF] share price is $1,501.31. The Score for PGPHF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • PGPHF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PGPHF Stock Price Chart

What is Partners Group Holding AG's stock price today?

  • The Partners Group Holding AG share price today is $1,501.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PGPHF is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $283.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PGPHF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.39 Sell
Relative Strength Index (14 RSI): 51.24 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1467.39 - 1552.55) Sell
Bollinger Bands (100): (1392 - 1521.92) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 68.89 Buy
Chaikin Money Flow: 1798941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (239.98 - 259.48) Buy
Bollinger Bands (100): (240.26 - 271.94) Buy

PGPHF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1479.66 Buy
20-day SMA: 1495.45 Buy
50-day SMA: 1498.96 Buy
200-day SMA: 1417.18 Buy
8-day EMA: 1484.56 Buy
20-day EMA: 1492.8 Buy
50-day EMA: 1488.27 Buy
200-day EMA: 1425.01 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 251.71 Buy
20-day SMA: 247.77 Buy
50-day SMA: 256.39 Buy
200-day SMA: 250.79 Buy
8-day EMA: 256.23 Buy
20-day EMA: 252.43 Buy
50-day EMA: 253.95 Buy
200-day EMA: 242.96 Buy

Partners Group Holding AG Earnings Growth & PGPHF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.

Partners Group Holding AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):